StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
12
Publishing Date
2023 - 05 - 25
1
2023 - 05 - 17
1
2023 - 01 - 10
1
2022 - 11 - 28
1
2022 - 11 - 02
1
2022 - 09 - 19
1
2022 - 09 - 16
1
2022 - 08 - 16
1
2022 - 06 - 24
1
2022 - 05 - 31
1
2022 - 05 - 17
1
2021 - 11 - 12
1
Sector
Commercial services
1
Consumer non-durables
1
Health services
1
Health technology
12
Manufacturing
2
N/a
1
Tags
Asco
1
Cancer
2
Cell
1
Covid-19
1
Disease
1
Drug
1
Global
5
Growing
1
Growth
2
Isa101
1
Lung
1
Market
7
Meeting
1
N/a
12
Positive
1
Report
2
Reqorsa
1
Research
1
Stroke
1
System
1
Therapeutics
4
Therapy
1
Treatment
1
Trends
1
Trial
1
Entities
Abbott laboratories
2
Abbvie inc.
1
Amgen inc.
2
Astrazeneca plc
12
Baxter international inc.
1
Biogen inc.
2
Bristol-myers squibb company
5
Chemocentryx, inc.
1
Eli lilly and company
4
Endo international plc
1
Genprex, inc.
1
Glaxosmithkline plc
3
Johnson & johnson
3
Laboratory corporation of america holdings
1
Mallinckrodt plc
1
Medtronic plc
1
Novartis ag
6
Pfizer, inc.
2
Qiagen n.v.
1
Quest diagnostics incorporated
1
Reckitt benckiser group plc
1
Sanofi
6
Sotera health company
1
Takeda pharmaceutical company limited
1
Teva pharmaceutical industries limited
1
Teva pharmaceutical industries ltd
3
Thermo fisher scientific inc
1
Vaxart, inc.
1
Symbols
AAPL
49
ABT
52
ACAQ
63
ALB
43
AM
42
AMGN
44
APO
78
AR
45
ARVL
187
AVNW
41
BDX
39
BMO
43
CLLS
51
CNHI
53
CNXC
55
DHR
43
DOV
92
ERIC
41
EXTR
39
FATP
42
FE
51
FMC
67
FNCTF
353
FRBA
95
GE
40
HEPA
39
HON
47
HUBS
112
IGT
56
JNJ
177
LLY
94
LTUM
41
LYV
58
MDT
39
MFC
67
MMM
39
MS
399
MSFT
47
NDAQ
79
OKE
62
OOMA
55
ORCL
40
PAYD
43
PPRUF
51
PPRUY
51
PSN
45
RY
40
SNOW
67
SNY
185
SNYNF
159
SRE
42
STRO
40
TMO
52
TOL
48
UNVR
39
VRTS
84
VSAC
45
VZ
39
WSFS
42
XYF
54
Exchanges
Nasdaq
12
Nyse
10
Crawled Date
2023 - 05 - 25
1
2023 - 05 - 17
1
2023 - 01 - 10
1
2022 - 11 - 28
1
2022 - 11 - 02
1
2022 - 09 - 19
1
2022 - 09 - 16
1
2022 - 08 - 16
1
2022 - 06 - 24
1
2022 - 06 - 01
1
2022 - 05 - 17
1
2021 - 11 - 12
1
Crawled Time
00:00
17
00:20
4
01:00
16
02:00
12
03:00
12
04:00
10
04:20
9
05:00
8
06:00
8
07:00
12
08:00
5
09:00
16
10:00
13
11:00
18
12:00
23
12:20
10
12:30
4
13:00
16
13:15
1
13:20
8
13:30
7
14:00
21
14:15
1
14:20
5
14:30
5
15:00
17
15:20
9
15:30
7
16:00
23
16:20
2
17:00
19
18:00
18
19:00
24
20:00
15
21:00
12
22:00
18
23:00
26
Source
ir.chemocentryx.com
1
www.prnewswire.com
11
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
AZNCF
crawled time :
21:00
save search
Genprex Publishes Positive Clinical Data from Phase 1 Portion of Acclaim-1 Clinical Trial Evaluating REQORSA® Immunogene Therapy in Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
Published:
2023-05-25
(Crawled : 21:00)
- prnewswire.com
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
-6.82%
|
O:
-0.47%
H:
0.0%
C:
-0.02%
GNPX
|
$2.21
500
|
Health Technology
|
160.0%
|
O:
3.65%
H:
7.04%
C:
1.02%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
-0.82%
|
O:
1.06%
H:
0.48%
C:
-0.04%
reqorsa
lung
asco
positive
cancer
cell
meeting
trial
therapy
Over-The-Counter Drug Market size to grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories and Achelios Therapeutics Inc. emerge as key contributors to market growth - Technavio
Published:
2023-05-17
(Crawled : 21:00)
- prnewswire.com
RBGPF
|
News
|
$53.94
3.4K
|
Consumer Non-Durables
|
-32.95%
|
O:
-0.55%
H:
2.89%
C:
-0.35%
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
7.3%
|
O:
-4.32%
H:
1.69%
C:
1.69%
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
-8.05%
|
O:
1.82%
H:
0.0%
C:
-2.3%
RBGLY
|
News
|
$10.98
860K
|
Manufacturing
|
-32.93%
|
O:
-0.18%
H:
0.24%
C:
-0.08%
NVS
|
News
|
$98.67
0.33%
260K
|
Health Technology
|
-2.84%
|
O:
-0.49%
H:
0.42%
C:
-0.37%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
13.06%
|
O:
-1.55%
H:
0.11%
C:
-1.04%
ABT
|
News
|
$106.535
-0.33%
510K
|
Health Technology
|
-1.77%
|
O:
-0.08%
H:
0.1%
C:
-0.24%
SNY
|
News
|
$49.085
5.31%
1.2M
|
Health Technology
|
-11.89%
|
O:
0.16%
H:
0.0%
C:
0.0%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
-4.69%
|
O:
0.28%
H:
0.31%
C:
-0.93%
drug
therapeutics
growth
market
Global Nasal Vaccines Markets and Pipeline Analysis Research Report 2022: A Major Game Changer in Blocking the Transmission of Diseases Such as COVID-19
Published:
2023-01-10
(Crawled : 21:00)
- prnewswire.com
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
-5.98%
|
O:
-1.28%
H:
0.0%
C:
-0.82%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
-0.56%
|
O:
-0.33%
H:
0.13%
C:
-1.28%
covid-19
research
global
report
Acute Ischemic Stroke Therapeutics Market: Growth Opportunities led by Athersys Inc. and Bayer AG - Technavio
Published:
2022-11-28
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
4.69%
|
O:
0.36%
H:
0.16%
C:
0.16%
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
1.08%
|
O:
-1.93%
H:
0.0%
C:
0.0%
MDT
|
$79.69
-0.86%
400K
|
Health Technology
|
5.58%
|
O:
0.35%
H:
0.99%
C:
0.1%
JNJ
|
News
|
$147.46
-0.72%
820K
|
Health Technology
|
-16.46%
|
O:
-0.18%
H:
0.14%
C:
-0.52%
SNY
|
News
|
$49.085
5.31%
1.2M
|
Health Technology
|
3.68%
|
O:
0.01%
H:
0.0%
C:
0.0%
BIIB
|
$198.365
-1.8%
310K
|
Health Technology
|
-30.8%
|
O:
-0.27%
H:
0.99%
C:
0.11%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
7.54%
|
O:
0.21%
H:
0.16%
C:
-0.41%
AMGN
|
News
|
$268.16
-1.78%
290K
|
Health Technology
|
-3.4%
|
O:
0.27%
H:
0.0%
C:
-0.49%
stroke
therapeutics
growth
Peptide Therapeutics Global Market to Reach $52.19 Billion by 2026 at a CAGR of 8.9%
Published:
2022-11-02
(Crawled : 21:00)
- prnewswire.com
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
7.91%
|
O:
-0.7%
H:
0.29%
C:
0.29%
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
12.79%
|
O:
-2.33%
H:
3.2%
C:
3.2%
PFE
|
News
4
|
$25.805
-1.77%
3.8M
|
Health Technology
|
-44.19%
|
O:
-1.51%
H:
0.95%
C:
0.45%
BMY
|
$45.36
-7.16%
10M
|
Health Technology
|
-36.91%
|
O:
-0.26%
H:
1.87%
C:
1.59%
SNY
|
News
|
$49.085
5.31%
1.2M
|
Health Technology
|
9.75%
|
O:
-1.85%
H:
0.0%
C:
0.0%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
19.26%
|
O:
-1.31%
H:
1.98%
C:
1.71%
global
therapeutics
market
Global Central Nervous System Therapeutics Market to Grow at Healthy CAGR Due to Rising Disorder Prevalence & Technical Advancements
Published:
2022-09-19
(Crawled : 21:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
28.06%
|
O:
-6.97%
H:
7.7%
C:
-0.76%
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
21.98%
|
O:
-0.34%
H:
6.64%
C:
-0.06%
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
51.28%
|
O:
1.96%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.67
0.33%
260K
|
Health Technology
|
21.83%
|
O:
-0.82%
H:
0.07%
C:
-0.61%
JNJ
|
News
|
$147.46
-0.72%
820K
|
Health Technology
|
-10.62%
|
O:
-0.33%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
32.75%
|
O:
-0.71%
H:
0.2%
C:
-0.23%
LLY
|
News
|
$724.615
-1.04%
480K
|
Health Technology
|
146.55%
|
O:
-0.42%
H:
0.0%
C:
-0.69%
SNY
|
News
|
$49.085
5.31%
1.2M
|
Health Technology
|
17.66%
|
O:
-1.18%
H:
0.0%
C:
0.0%
BIIB
|
$198.365
-1.8%
310K
|
Health Technology
|
-3.47%
|
O:
-0.71%
H:
0.08%
C:
-1.72%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
22.78%
|
O:
-1.16%
H:
0.56%
C:
0.14%
AMGN
|
News
|
$268.16
-1.78%
290K
|
Health Technology
|
18.31%
|
O:
-0.98%
H:
0.65%
C:
-0.35%
global
system
therapeutics
market
Sickle Cell Disease Treatment Global Market to Reach $4 Billion by 2027
Published:
2022-09-16
(Crawled : 21:00)
- prnewswire.com
BMY
|
$45.36
-7.16%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
Email alert
Add to watchlist
BAX
|
$40.005
-2.26%
670K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.67
0.33%
260K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
disease
market
Global $30+ Billion Cervical Cancer Drugs Market, 2022-2026 - Pipeline Drugs ISA101, AGEN2034, and Z-100 Anticipated to Drive the Market
Published:
2022-08-16
(Crawled : 21:00)
- prnewswire.com
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
0.91%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.67
0.33%
260K
|
Health Technology
|
14.6%
|
O:
-0.7%
H:
0.55%
C:
0.0%
LLY
|
News
|
$724.615
-1.04%
480K
|
Health Technology
|
142.41%
|
O:
-0.1%
H:
3.42%
C:
2.2%
BMY
|
$45.36
-7.16%
10M
|
Health Technology
|
-34.09%
|
O:
-0.3%
H:
1.45%
C:
0.88%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
6.68%
|
O:
0.46%
H:
0.46%
C:
-0.94%
isa101
global
cancer
market
Global Opioids Market to 2027 - Size, Share & Industry Trends Analysis Report
Published:
2022-06-24
(Crawled : 21:00)
- prnewswire.com
ENDP
|
News
|
$0.2926
-9.6%
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
Email alert
Add to watchlist
MNKKQ
|
$0.02
|
Manufacturing
|
Email alert
Add to watchlist
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$25.805
-1.77%
3.8M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
Email alert
Add to watchlist
SNY
|
News
|
$49.085
5.31%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
trends
report
market
ChemoCentryx Announces Changes to its Board of Directors
Published:
2022-05-31
(Crawled : 21:00)
- ir.chemocentryx.com
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
3.52%
|
O:
2.31%
H:
0.0%
C:
-3.37%
SHC
|
$11.11
-1.42%
87K
|
Commercial Services
|
-46.69%
|
O:
0.09%
H:
1.37%
C:
0.66%
ABT
|
News
|
$106.535
-0.33%
510K
|
Health Technology
|
-7.54%
|
O:
-0.04%
H:
2.19%
C:
1.64%
VXRT
|
News
|
$0.7
-1.37%
330K
|
Health Technology
|
-80.97%
|
O:
-0.27%
H:
2.96%
C:
-2.15%
CCXI
|
News
|
$51.99
-0.04%
|
Health Technology
|
122.08%
|
O:
0.0%
H:
0.0%
C:
-4.87%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
5.64%
|
O:
-2.24%
H:
1.32%
C:
0.9%
Insights on the Precision Medicine Global Market to 2027 - by Product, Technology, Application, End-user and Region
Published:
2022-05-17
(Crawled : 21:00)
- prnewswire.com
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
4.74%
|
O:
-0.23%
H:
0.0%
C:
-2.66%
TMO
|
News
|
$574.13
-0.57%
260K
|
Health Technology
|
4.22%
|
O:
-0.87%
H:
0.0%
C:
0.0%
DGX
|
News
|
$135.45
-1.53%
100K
|
Health Services
|
-2.11%
|
O:
-0.72%
H:
0.59%
C:
-0.22%
QGEN
|
$40.76
-1.83%
310K
|
Health Technology
|
-9.52%
|
O:
-2.2%
H:
0.85%
C:
-2.05%
NVS
|
News
|
$98.67
0.33%
260K
|
Health Technology
|
11.61%
|
O:
-0.31%
H:
0.53%
C:
-0.19%
LH
4
|
$202.875
-2.44%
160K
|
Health Services
|
-15.46%
|
O:
1.09%
H:
0.0%
C:
0.0%
LLY
|
News
|
$724.615
-1.04%
480K
|
Health Technology
|
149.57%
|
O:
-0.09%
H:
0.0%
C:
0.0%
BMY
|
$45.36
-7.16%
10M
|
Health Technology
|
-36.51%
|
O:
1.57%
H:
0.0%
C:
0.0%
QGEN
|
$40.76
-1.83%
310K
|
Health Technology
|
-9.52%
|
O:
-2.2%
H:
0.85%
C:
-2.05%
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
8.74%
|
O:
-1.92%
H:
0.5%
C:
-1.4%
market
Worldwide Active Pharmaceutical Ingredient Industry to 2030 - Growing Importance of Generics is Driving the Market
Published:
2021-11-12
(Crawled : 21:00)
- prnewswire.com
LLY
|
News
|
$724.615
-1.04%
480K
|
Health Technology
|
Email alert
Add to watchlist
TEVA
|
$13.06
0.38%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.46
-0.72%
820K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.67
0.33%
260K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$135.35
400
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$45.36
-7.16%
10M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
0
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.93
0.17%
170K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$75.19
5.6%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$49.085
5.31%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.115
-0.87%
260K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
2.6K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$166.41
-0.83%
860K
|
Health Technology
|
Email alert
Add to watchlist
growing
Gainers vs Losers
46%
54%
Top 10 Gainers
SGBX
|
$0.26
80.43%
54M
|
Producer Manufacturing
LICN
|
$1.0
78.57%
3.3M
|
CSSE
4
|
$0.2656
74.39%
9.7M
|
Consumer Services
BRFH
4
|
$1.89
71.82%
32M
|
Manufacturing
ACON
|
$0.49
70.14%
24M
|
n/a
BOF
|
$1.95
66.67%
920K
|
MTC
|
$3.62
61.61%
790K
|
Technology Services
AMST
|
$3.22
61.0%
720K
|
Technology Services
PCSA
|
$2.28
40.74%
37M
|
Producer Manufacturing
EVA
|
$0.626
39.14%
2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.